Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Report the molecular scores (probability) of lung transplant disease in a reference set of 600 transbronchial biopsies.
Timeframe: two years
Report the molecular diagnoses of the MMDx-TBB system
Timeframe: two years